Search - tctmd.com

Displaying 81 - 100 of 196

Sort: Relevancy | Date

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Presentation ESC 2014

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Presenter: Petr Widimsky

September 02, 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Presentation ESC 2014

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Presenter: Robert A. Henderson

September 02, 2014

News Conference News ESC 2014

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

September 02, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

September 02, 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presentation ESC 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presenter: Thomas Pilgrim

September 01, 2014

Presentation ESC 2014

MITOCARE Study

Presenter: Dan Atar

September 01, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

September 01, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

September 01, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

September 01, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.